For health professionals, repeated SARS-CoV-2 RNA detection through PCR combined with properly validated serologic assays for the presence of anti-IgM and anti-IgG antibodies should be mandatory.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753729 | PMC |
| http://dx.doi.org/10.1002/ccr3.3547 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Two-month follow-up of persons with SARS-CoV-2 infection-Zambia, September 2020: a cohort study.
Pan Afr Med J
March 2022
Department of Infectious Disease and Control, University Teaching Hospital, Lusaka, Zambia.
Introduction: COVID-19 is often characterized by an acute upper respiratory tract infection. However, information on longer-term clinical sequelae following acute COVID-19 is emerging. We followed a group of persons with COVID-19 in Zambia at two months to assess persistent symptoms.
View Article and Find Full Text PDFProlonged 59-day course of COVID-19: The case of a SARS-CoV-2 shedding persistency in a healthcare provider.
Clin Case Rep
January 2021
Odontology CHRU de Brest Brest France.
For health professionals, repeated SARS-CoV-2 RNA detection through PCR combined with properly validated serologic assays for the presence of anti-IgM and anti-IgG antibodies should be mandatory.
View Article and Find Full Text PDFEffect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial.
JAMA Netw Open
July 2020
Vascular Biology Center, Division of Hematology-Oncology-Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis.
Importance: Sickle cell disease (SCD) is characterized by chronic pain and episodic acute pain caused by vasoocclusive crises, often requiring high doses of opioids for prolonged periods. In humanized mouse models of SCD, a synthetic cannabinoid has been found to attenuate both chronic and acute hyperalgesia. The effect of cannabis on chronic pain in adults with SCD is unknown.
View Article and Find Full Text PDFBackground: Neonatal illness, particularly in the first week of life, is a leading cause of death worldwide. Improving identification of young infants who require referral for severe illness is of major public-health importance.
Methods: Infants under 2 months of age brought with illness to health facilities in Bangladesh, Bolivia, Ghana, India, Pakistan, and South Africa were recruited in two age-groups: 0-6 days and 7-59 days.
Novel mutations in the respiratory syncytial virus G gene identified in viral isolates from a girl with severe combined immune deficiency treated with intravenous immune globulin.
J Clin Virol
November 2006
Department of Pediatrics, Section of Critical Care, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, United States.
Background: Respiratory syncytial virus (RSV) can cause prolonged infections in individuals with compromised immunity.
Objectives: To investigate whether RSV evolves during prolonged infection in an immunocompromised host.
Study Design: We sequenced the envalope glycoprotein genes of RSV obtained at three time points during a 59-day period from a 4-year-old female with severe combined immune deficiency (SCID) treated with intravenous immunoglobulin (IVIG).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!